|
|
41
|
|
|
4181BE
|
|
|
KEYTRUDA 25MG/ML INJ (MSD) PEMBROLI (C)
|
|
|
PEMBROLIZUMAB
|
|
|
KEYTRUDA
|
|
|
4ML VIAL
|
|
|
C
|
|
|
9766.5
|
|
|
9766.5032
|
|
|
25MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
MSD
|
|
|
MERCK SHARP & DOHME (I.A.) CORP
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|